| HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse N El-Hage, M Rodriguez, SM Dever, RR Masvekar, DA Gewirtz, ... Journal of virology 89 (2), 1024-1035, 2015 | 82 | 2015 |
| Molecular‐based diagnosis of multiple sclerosis and its progressive stage C Barbour, P Kosa, M Komori, M Tanigawa, R Masvekar, T Wu, ... Annals of neurology 82 (5), 795-812, 2017 | 45 | 2017 |
| Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity R Masvekar, T Wu, P Kosa, C Barbour, V Fossati, B Bielekova Multiple sclerosis and related disorders 28, 34-43, 2019 | 40 | 2019 |
| Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization CK Arnatt, BA Falls, Y Yuan, TJ Raborg, RR Masvekar, N El-Hage, ... Bioorganic & medicinal chemistry 24 (22), 5969-5987, 2016 | 32 | 2016 |
| Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality RR Masvekar, P Kosa, K Jin, K Dobbs, MA Stack, R Castagnoli, ... Annals of Clinical and Translational Neurology 9 (5), 622-632, 2022 | 23 | 2022 |
| Idebenone does not inhibit disability progression in primary progressive MS P Kosa, T Wu, J Phillips, M Leinonen, R Masvekar, M Komori, A Wichman, ... Multiple sclerosis and related disorders 45, 102434, 2020 | 22 | 2020 |
| Neurofilament light chain levels correlate with clinical measures in CLN3 disease AND Do, N Sinaii, RR Masvekar, EH Baker, AE Thurm, AG Soldatos, ... Genetics in Medicine 23 (4), 751-757, 2021 | 21 | 2021 |
| Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability JM Balinang, RR Masvekar, KF Hauser, PE Knapp AIDS 31 (6), 753-764, 2017 | 21 | 2017 |
| GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity RR Masvekar, N El-Hage, KF Hauser, PE Knapp Molecular and Cellular Neuroscience 65, 11-20, 2015 | 21 | 2015 |
| Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects. KPE Hahn YK, Masvekar RR, Xu R, Hauser KF Curr HIV Res. 13 (1), 10-20, 2015 | 20* | 2015 |
| Morphine Enhances HIV-1SF162-Mediated Neuron Death and Delays Recovery of Injured Neurites RR Masvekar, N El-Hage, KF Hauser, PE Knapp PLoS One 9 (6), e100196, 2014 | 17 | 2014 |
| Cerebrospinal fluid biomarkers of myeloid and glial cell activation are correlated with multiple sclerosis lesional inflammatory activity R Masvekar, J Phillips, M Komori, T Wu, B Bielekova Frontiers in Neuroscience 15, 649876, 2021 | 13 | 2021 |
| Quantifications of CSF apoptotic bodies do not provide clinical value in multiple sclerosis R Masvekar, J Mizrahi, J Park, PR Williamson, B Bielekova Frontiers in Neurology 10, 496438, 2019 | 12 | 2019 |
| Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual … A Abdelhak, L Barba, M Romoli, P Benkert, F Conversi, L D’Anna, ... Journal of neurology 270 (7), 3315-3328, 2023 | 11 | 2023 |
| Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1 N Agrawal, NY Farhat, N Sinaii, AD Do, C Xiao, E Berry-Kravis, ... Genetics in Medicine 25 (3), 100349, 2023 | 8 | 2023 |
| Enhancing the clinical value of serum neurofilament light chain measurement P Kosa, R Masvekar, M Komori, J Phillips, V Ramesh, M Varosanec, ... JCI insight 7 (15), 2022 | 7 | 2022 |
| Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures M Abdennadher, S Inati, A Soldatos, G Norato, EH Baker, A Thurm, ... Journal of inherited metabolic disease 44 (4), 1013-1020, 2021 | 5 | 2021 |
| Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury D Wilson, D Chan, L Chang, R Mathis, I Verberk, X Montalban, ... Clinical Chemistry and Laboratory Medicine (CCLM) 62 (2), 322-331, 2024 | 4 | 2024 |
| Drug library screen identifies inhibitors of toxic astrogliosis R Masvekar, P Kosa, C Barbour, JL Milstein, B Bielekova Multiple sclerosis and related disorders 58, 103499, 2022 | 3 | 2022 |
| Molecular mechanisms associated with multiple sclerosis progression, severity and phenotype P Kosa, K Lumbard, J Wang, CJ Liang, R Masvekar, Y Kim, M Varosanec, ... medRxiv, 2022.10. 14.22281095, 2022 | 2 | 2022 |
Bibiana BielekovaNeuroimmunological Diseases Section, NIAID, NIH (National Institutes of Health)Підтверджена електронна адреса в nih.gov
